MODULATING PHOSPHATASE ACTIVITY IN CARDIAC CELLS
- 专利权人:
- 发明人:
- Roger J. Hajjar,Federica del Monte,Evangelia Kranias
- 申请号:
- US15065507
- 公开号:
- US20180296578A1
- 申请日:
- 2016.03.09
- 申请国别(地区):
- US
- 年份:
- 2018
- 代理人:
- 摘要:
- Expression of a phosphatase inhibitor in heart cells can be used to treat cardiac disorders, e.g., heart failure. Decreasing phosphatase activity can improve β-adrenergic responsiveness.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- R2R1/2 GENE FOR TREATING AND DIAGNOSING CARDIAC AND PULMONARY DISEASES OR CONDITIONS AND CANCER
- Methods for Administration and Methods for Treating Cardiovascular Diseases with Resiniferatoxin
- Methods for Administration and Methods for Treating Cardiovascular Diseases with Resiniferatoxin
- METHODS FOR ADMINISTRATION AND METHODS FOR TREATING CARDIOVASCULAR DISEASES WITH RESINIFERATOXIN
- CARDIOSPHERE-DERIVED CELLS AND THEIR EXTRACELLULAR VESICLES TO RETARD OR REVERSE AGING AND AGE-RELATED DISORDERS